This nuanced exploration sheds light on novel insights into the intricate interplay between insulin and mitochondrial metabolism in the brain (Fig. 9), unraveling potential therapeutic targets for mitigating the cascading effects of brain insulin resistance development in the context of neurodegenerative diseases. This evidence concerns the gene INS and neurodegenerative disease.